These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 32000820

  • 1. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW, Seto MTY, Ng EHY.
    Trials; 2020 Jan 30; 21(1):121. PubMed ID: 32000820
    [Abstract] [Full Text] [Related]

  • 2. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix.
    Hezelgrave NL, Watson HA, Ridout A, Diab F, Seed PT, Chin-Smith E, Tribe RM, Shennan AH.
    BMC Pregnancy Childbirth; 2016 Nov 21; 16(1):358. PubMed ID: 27871275
    [Abstract] [Full Text] [Related]

  • 3. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, Molina FS, Savvidou M, De La Calle M, Persico N, Quezada Rojas MS, Sau A, Greco E, O'Gorman N, Plasencia W, Pereira S, Jani JC, Valino N, Del Mar Gil M, Maclagan K, Wright A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2021 Jan 21; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [Abstract] [Full Text] [Related]

  • 4. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A, Romero R, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Erez O, Pacora P, Nicolaides KH.
    Am J Obstet Gynecol; 2018 Jul 21; 219(1):10-25. PubMed ID: 29630885
    [Abstract] [Full Text] [Related]

  • 5. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD, Koullali B, Naaktgeboren CA, Schuit E, Bekedam DJ, Moll E, Oudijk MA, van Baal WM, de Boer MA, Visser H, van Drongelen J, van de Made FW, Vollebregt KC, Muller MA, Bekker MN, Brons JTJ, Sueters M, Langenveld J, Franssen MT, Schuitemaker NW, van Beek E, Scheepers HCJ, de Boer K, Tepe EM, Huisjes AJM, Hooker AB, Verheijen ECJ, Papatsonis DN, Mol BWJ, Kazemier BM, Pajkrt E.
    BMC Pregnancy Childbirth; 2017 Sep 04; 17(1):284. PubMed ID: 28870155
    [Abstract] [Full Text] [Related]

  • 6. Utility of follow-up cervical length screening in low-risk women with a cervical length of 26 to 29 mm.
    Boelig RC, Kripalu V, Chen SL, Cruz Y, Roman A, Berghella V.
    Am J Obstet Gynecol; 2021 Aug 04; 225(2):179.e1-179.e6. PubMed ID: 33652056
    [Abstract] [Full Text] [Related]

  • 7. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'Brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW, PREGNANT Trial.
    Ultrasound Obstet Gynecol; 2011 Jul 04; 38(1):18-31. PubMed ID: 21472815
    [Abstract] [Full Text] [Related]

  • 8. Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.
    Romero R, Nicolaides KH, Conde-Agudelo A, O'Brien JM, Cetingoz E, Da Fonseca E, Creasy GW, Hassan SS.
    Ultrasound Obstet Gynecol; 2016 Sep 04; 48(3):308-17. PubMed ID: 27444208
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.
    Cabrera-García L, Cruz-Melguizo S, Ruiz-Antorán B, Torres F, Velasco A, Martínez-Payo C, Avendaño-Solá C, PESAPRO trial Group.
    Trials; 2015 Sep 25; 16():427. PubMed ID: 26407852
    [Abstract] [Full Text] [Related]

  • 10. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A, Romero R.
    Am J Obstet Gynecol; 2016 Feb 25; 214(2):235-242. PubMed ID: 26450404
    [Abstract] [Full Text] [Related]

  • 11. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct 25; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 12. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J, Lynne S.
    J Midwifery Womens Health; 2012 Jul 25; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [Abstract] [Full Text] [Related]

  • 13. [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?].
    Rozenberg P.
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec 25; 45(10):1337-1345. PubMed ID: 28166925
    [Abstract] [Full Text] [Related]

  • 14. Comparing cervical cerclage, pessary and vaginal progesterone for prevention of preterm birth in women with a short cervix (SuPPoRT): A multicentre randomised controlled trial.
    Hezelgrave NL, Suff N, Seed P, Robinson V, Carter J, Watson H, Ridout A, David AL, Pereira S, Hoveyda F, Girling J, Vinayakarao L, Tribe RM, Shennan AH, SuPPoRT Collaborating Team.
    PLoS Med; 2024 Jul 25; 21(7):e1004427. PubMed ID: 39012912
    [Abstract] [Full Text] [Related]

  • 15. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.
    Saccone G, Maruotti GM, Giudicepietro A, Martinelli P, Italian Preterm Birth Prevention (IPP) Working Group.
    JAMA; 2017 Dec 19; 318(23):2317-2324. PubMed ID: 29260226
    [Abstract] [Full Text] [Related]

  • 16. SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth.
    Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Biggio J, SMFM Publications Committee.
    Am J Obstet Gynecol; 2024 Aug 19; 231(2):B2-B13. PubMed ID: 38754603
    [Abstract] [Full Text] [Related]

  • 17. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks' gestation: open label, multicentre, randomised, controlled trial.
    van Dijk CE, van Gils AL, van Zijl MD, Koullali B, van der Weide MC, van den Akker ES, Hermsen BJ, van Baal WM, Visser H, van Drongelen J, Vollebregt KC, Muller M, van der Made FW, Gordijn SJ, de Mooij YM, Oudijk MA, de Boer MA, Mol BW, Kazemier BM, Pajkrt E, Quadruple P Research Group.
    BMJ; 2024 Mar 12; 384():e077033. PubMed ID: 38471724
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness of vaginal progesterone to prevent preterm birth in singleton pregnant women with a short cervix at 18-32 weeks gestation.
    Wang X, Maerdan M, Xi J, Zhang M, Yang H, Shi C.
    J Matern Fetal Neonatal Med; 2024 Dec 12; 37(1):2412751. PubMed ID: 39406681
    [Abstract] [Full Text] [Related]

  • 19. Cervical elastography in predicting spontaneous preterm birth in singleton pregnancy with a short cervix receiving progesterone treatment at 18 to 24 weeks' gestation.
    He B, Zhou Y, Cao L, Yao B, Gao H, Zhang H.
    J Matern Fetal Neonatal Med; 2024 Dec 12; 37(1):2347954. PubMed ID: 38714523
    [Abstract] [Full Text] [Related]

  • 20. Cervical cerclage for short cervix at 24 to 26 weeks of gestation: systematic review and meta-analysis of randomized controlled trials using individual patient-level data.
    Gulersen M, Lenchner E, Nicolaides KH, Otsuki K, Rust OA, Althuisius S, Bornstein E, Berghella V.
    Am J Obstet Gynecol MFM; 2023 Jun 12; 5(6):100930. PubMed ID: 36924844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.